FdaApplication
ANDA 212257
Identifiers
- fda_app_no: ANDA212257
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2024-09-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PROCHLORPERAZINE EDISYLATE | PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | INJECTABLE;INJECTION |
1 product